MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks,the primary endpoint in a 36 week serial liver biopsy study期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks,the primary endpoint in a 36 week serial liver biopsy study

Authors:	S. Harrison S. Moussa M. Bashir N. Alkhouri J. Frias S. Baum B. Tetri M. Bansal R. Taub

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！